Rossari Biotech Schedules Q1 Earnings Call for July 20 Amidst 14% Margin Expansion Targets
Rossari Biotech will discuss its Q1 FY27 performance on July 20, with institutional investors focusing on margin recovery in the HPPC segment and export volume growth.
Read the full articleYou might also wanna read
Pharma companies' Q1 margins likely to decline despite revenue growth: Goldman Sachs
New Delhi [India], July 9 (ANI): Indian pharmaceutical companies are expected to report improved revenues in the first quarter of FY2026-27,
BPI's mid-year report highlights 2026 biotech trends
As we coast into July, BioProcess International looks back at some of the stories and enduring trends that defined the first half of 2026.
Capri Holdings forecasts FY2027 EPS of $2.15 on $3.525B revenue with 200 bps margin expansion
Capri Holdings (CPRI) Q4 FY2026 earnings call recap: FY2027 revenue/EPS outlook, margin expansion, Kors reset, tariffs & buybacks—read key i
seekingalpha.com·1mo agoInvestors Pile Into SK Hynix’s ADR Ahead of a Big Week of Earnings, Econ Data: July 10, 2026
Markets are mixed as investors pile into SK Hynix’s ADR listing while taking profits in other AI-related stocks prior to earnings season kic
Q1 Results Today Live: HCL Technologies, ICICI Prudential AMC, Nuvoco Vistas Corporation, Bajaj Consumer Care, Khaitan Chemicals to announce Q1 results
Q1 Results Today, July 13, 2026, Live Updates: Follow businessline's Q1 updates here
Stocks To Watch Today: HCLTech, BEL, Poonawalla Fincorp, Emcure Pharmaceuticals and More
Several companies are expected to remain in focus on July 14 after announcing fundraising plans, order wins, acquisitions and board approval
Comments
Sign in to join the conversation.
No comments yet. Be the first.